中國生物製藥(01177)終止境內上市輔導 X
08/02/2023 23:08
<匯港通訊>         中國生物製藥(01177)宣布，基於目前市場狀況及該公司發展規劃的考量，該公司已決定不再繼續進行建議境內發行。該公司與上市輔導機構一致同意終止有關建議境內發行的上市輔導協議及其項下所有輔導工作，並已向中國證監會(北京監管局)報告終止情況。該公司將綜合考慮市場狀況和發展需要，規劃未來相關安排。(WH)

(C) Copyright by Infocast Ltd. All Rights Reserved.

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.